FDA Advisory Committee To Review Human Genome Sciences' Anthrax Treatment
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. government already has a stockpile of Human Genome Sciences' ABthrax (raxibacumab) for emergency use.